GoldenGolden
Spring Bank Pharmaceuticals, Inc.

Spring Bank Pharmaceuticals, Inc.

Spring Bank Pharmaceuticals, Inc. is a company founded in 2002

Spring Bank Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that engages in the discovery and development of therapeutics utilizing small molecule nucleic acid hybrid (SMNH) chemistry platforms.

Timeline

October 2013
Spring Bank Pharmaceuticals, Inc. raises a $9,400,000 series A round from Aescap Venture, Atlas Venture, M Ventures, MP Healthcare Venture Management, Sr One and TVM Capital.
2012
Spring Bank Pharmaceuticals, Inc. was founded by Florian Ruker.
April 2011
Spring Bank Pharmaceuticals, Inc. raises a $18,000,000 venture round from Aescap Venture, Atlas Venture, M Ventures, MP Healthcare Venture Management, Novo Ventures, Sr One and TVM Capital.
January 2010
Spring Bank Pharmaceuticals, Inc. raises a $9,600,000 series A round from Aescap Venture, Atlas Venture, M Ventures, MP Healthcare Venture Management, Novo Ventures and TVM Capital.
November 2007
Spring Bank Pharmaceuticals, Inc. raises a $3,600,000 series A round from Novo Ventures.
September 2007
Spring Bank Pharmaceuticals, Inc. raises a $7,200,000 series A round from Aescap Venture and Atlas Venture.
January 2007
Spring Bank Pharmaceuticals, Inc. raises a $1,800,000 seed round from Atlas Venture.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Spring Bank Pharmaceuticals, Inc.
November 20, 2020
www.prnewswire.com:443
/PRNewswire/ -- Please replace the release dated November 19, 2020 with the following corrected version due to revisions to the headline. The corrected release...
F-star Therapeutics, Inc.
November 20, 2020
www.prnewswire.com:443
/PRNewswire/ -- F-star Therapeutics, Inc., (Nasdaq: FSTX, as of November 23, 2020) a clinical-stage immuno-oncology company determined to transform the lives...
BioSpace
June 3, 2020
BioSpace
Clinical Poster for IV SB 11285 Phase 1a/1b trial presented at the American Society of Clinical Oncology (ASCO) Virtual Annual Meeting

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.